Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Weight loss | 16 | 17 | |
Epilepsy | 9 | 18 | |
Amyotrophic lateral sclerosis | 6 | 3 | |
Diabetes type 2 | 3 | 9 | |
Prediabetes | 3 | 4 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Weight loss | 6 | |
Headaches | 2 | |
Bad breath (halitosis) | 1 | |
Bowel irregularity | 1 | |
Constipation | 1 | |
Craving carbs | 1 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 1 | |
Moderate | 6 | |
Mild | 21 | |
None | 18 |
Member evaluations
S1103
evaluated on Feb 22, 2021
- Perceived effectiveness for diabetes type 2: Major
- Side effects: None
Tegid
evaluated on Aug 01, 2014
- Perceived effectiveness for epilepsy: Major
- Side effects: Mild
Mrpag13
evaluated on Mar 23, 2010
- Perceived effectiveness for epilepsy: Major
- Side effects: None